Christoph Loddenkemper, MD

Pathotres Joint Practice for Pathology
Berlin Germany Papers:
T.90 Targeting human CD2 by the monoclonal Antibody CB.219 reduces intestinal Inflammation in a humanized Transfer Colitis Model